A higher baseline HIV viral load increases the odds of an immunologic response in women living with HIV, except among those ...

Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

All I want is for HIV to end with me,” says a young woman renamed Dorothy Banda to safeguard her identity, rights and ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Global cuts to HIV research and support funding have the Joint United Nations Programme on HIV and AIDS (UNAIDS) worried ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...